ArticleInternational dental journal2026
Dysregulation of Pulpitis Progression Through Modulation of the lncRNA ITGB2-AS1 /miR-1224-5p Axis.
Article in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Molecular mechanism by which mir-153-3p attenuates pulpitis in human deciduous teeth via PTEN-targeted suppression of inflammation and oxidative stress.Odontology · 2026Article
- Long non-coding RNA FOXD2-AS1 promotes inflammation but suppresses osteogenesis in pulpitis via miR-338-3p/THBS1 axis.Odontology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
aimsThe onset of pulpitis is excruciatingly painful, and delayed treatment can lead to serious sequelae. LncRNAITGB2-AS1 is abnormally expressed in pulpitis samples, and thus, the present study was designed to investigate its diagnostic value and regulatory mechanisms in pulpitis.
methodsRT-qPCR was used to detect the expression of ITGB2-AS1 and miR-1224-5p in 85 cases of pulp tissue and 80 cases of normal tissue. ROC curves were evaluated for the diagnostic value of ITGB2-AS1. Cell proliferation and apoptosis were assayed by the CCK-8 kit and apoptosis kit, respectively. IL-6 and TNF-α levels were measured by ELISA; mRNA levels was assessed by RT-qPCR. SOD and MDA levels were determined using corresponding kits. PPI network analysis identified hub genes among the downstream target genes of miR-1224-5p.
resultsCompared with controls, in tissues from patients with pulpitis, ITGB2-AS1 levels were increased and miR-1224-5p levels were decreased. The diagnostic value of ITGB2-AS1 for pulpitis was 0.902, with a high specificity of 92.5%. ITGB2-AS1 can target miR-1224-5p and negatively regulate its expression. Knockout of ITGB2-AS1 significantly improved LPS-impaired cell proliferation, reduced apoptosis, and decreased inflammation and oxidative stress levels. Additionally, MAPK1 is a target of miR-1224-5p.
conclusionITGB2-AS1 exhibits high diagnostic value for pulpitis patients and holds promise as a novel diagnostic biomarker. Knocking down ITGB2-AS1 targets miR-1224-5p expression, mitigates cellular damage, and restores cellular vitality, thereby potentially slowing pulpitis progression. This establishes a theoretical foundation for positioning ITGB2-AS1 as a future therapeutic target for pulpitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.